MedTrace Logo

Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

NCT05535803 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-09-10

No results posted yet for this study

Summary

The trial evaluates the safety and efficacy of the olfactory mucosa-derived mesenchymal stem cells based therapy for the patients with chronic laryngeal and tracheal stenosis

Conditions

  • Tracheal Stenosis
  • Laryngeal Stenosis

Interventions

BIOLOGICAL

Olfactory mucosa-derived mesenchymal stem cells

Autologous olfactory mucosa-derived mesenchymal stem cells

OTHER

Patients treated according to current clinical protocols

Patients treated according to current clinical protocols

Sponsors & Collaborators

  • The Republican Center for Research and Practice in Otolaryngology

    collaborator UNKNOWN

  • Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

    lead OTHER_GOV

Principal Investigators

  • Andrei Hancharou, Dr · Institute for biophysics and cellular engineering NAS of Belarus

  • Elvira Strinkevich, Dr · The Republican Center for Research and Practice in Otolaryngology

  • Valery Chekan, Dr · The Republican Center for Research and Practice in Otolaryngology

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05535803 on ClinicalTrials.gov